British Journal of Experimental Pathology

British Journal of Experimental Pathology was a prominent peer-reviewed medical journal that focused on the experimental study of disease mechanisms. It served as a key forum for pioneering research in pathology and related biomedical sciences for much of the 20th century. The journal published original investigations into the etiology, pathogenesis, and pathological manifestations of diseases, contributing significantly to the foundation of modern experimental medicine. Its legacy is continued through its successor, the Journal of Pathology.

History and background

The journal was established in 1920, emerging during a period of rapid advancement in the biomedical sciences following the discoveries of figures like Louis Pasteur and Robert Koch. It was founded under the auspices of the Pathological Society of Great Britain and Ireland, reflecting a growing institutional commitment to experimental research. For decades, it provided a dedicated platform for pathologists and researchers to disseminate findings that bridged laboratory science and clinical medicine, operating alongside other seminal publications like the Journal of Pathology and Bacteriology. The editorial direction was historically influenced by leading figures in British medical research, maintaining its headquarters in London. Its publication run spanned a critical era that included the development of antibiotics and the rise of molecular biology, ceasing independent publication in 1987 when it merged with another title.

Scope and publication details

The journal's scope encompassed original research articles, brief communications, and reviews on all aspects of experimental pathology. This included studies on inflammation, neoplasia, infection, and immunopathology, often utilizing animal models and in vitro techniques to elucidate disease processes. It was published bimonthly by Blackwell Scientific Publications, a major academic publisher based in Oxford. The typical content featured investigations into cellular and molecular mechanisms, with frequent contributions from renowned institutions such as the Medical Research Council and various university departments across the United Kingdom and the Commonwealth of Nations. The readership primarily consisted of academic pathologists, biomedical researchers, and clinical scientists.

Abstracting and indexing

The journal was comprehensively covered by the major abstracting and indexing services of its time, ensuring wide dissemination of its research. It was indexed in core biomedical databases including Index Medicus, MEDLINE, and Science Citation Index. This indexing facilitated its use by researchers at institutions like the National Institutes of Health and the World Health Organization. Other services that included its content were Excerpta Medica, Chemical Abstracts Service, and Biological Abstracts. The consistent indexing in these services, managed by organizations like Thomson Reuters, underscored the journal's established role in the scientific literature and its importance for citation tracking and literature reviews.

Notable articles and impact

Throughout its history, the journal published numerous seminal papers that influenced the field of pathology. Early volumes contained important work on the pathogenesis of infectious diseases and the body's inflammatory response. In the mid-20th century, it featured groundbreaking studies on chemical carcinogenesis, the pathology of rheumatoid arthritis, and early investigations into transplant rejection. Research from laboratories at the Imperial Cancer Research Fund and the University of Cambridge frequently appeared in its pages. These contributions provided foundational knowledge that informed later advances in oncology, immunology, and toxicology, cementing the journal's reputation as a vital resource for experimental medical research.

Evolution into the Journal of Pathology

In 1987, the *British Journal of Experimental Pathology* was merged with the Journal of Pathology and Bacteriology, which by then had been renamed simply the Journal of Pathology. This consolidation was driven by a desire to create a stronger, unified publication covering the entire spectrum of pathological research, from molecular mechanisms to clinical and diagnostic pathology. The merger was orchestrated by the Pathological Society of Great Britain and Ireland in partnership with John Wiley & Sons, which assumed publishing responsibilities. The newly configured Journal of Pathology continued the legacy and ISSN of the former journal, maintaining its focus on high-impact experimental studies while expanding its scope to include modern techniques in molecular pathology and diagnostic pathology.

Category:Pathology journals Category:Publications established in 1920 Category:Publications disestablished in 1987 Category:Academic journals published in the United Kingdom